Kodiak Sciences Salaries & Compensation
Tech
Kodiak Sciences is a biopharmaceutical company that develops and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration. The company also has preclinical stage product candidates, including KSI-501 and KSI-601. Kodiak Sciences was incorporated in 2009 and is based in Palo Alto, California.
Headquarters:Palo Alto, United States
Founded:2009
Employees:51-200
Type:public
2
Salary entries
$113K
Avg total comp
$113K
Median total comp
USD
Currency
Stats shown in USD (converted). Select a country for accurate local figures.
Headquarters